While the second phase of the COVID vaccination process started on a positive note, parents are still awaiting a safe and a promising vaccine for their children. Given that the University of Oxford in collaboration with the pharmaceutical company Astrazeneca have begun its vaccine trial on children aged six to 17, they are yet to confirm the effectiveness of the vaccine on them.

While the second phase of the COVID vaccination process started on a positive note, parents are still awaiting a safe and a promising vaccine for their children. Given that the University of Oxford in collaboration with the pharmaceutical company Astrazeneca have begun its vaccine trial on children aged six to 17, they are yet to confirm the effectiveness of the vaccine on them.